Sirolimus Blocks the Accumulation of Hyaluronan (HA) by Arterial Smooth Muscle Cells and Reduces Monocyte Adhesion to the ECM

Overview

Journal Atherosclerosis

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2006 Dec 19

PMID 17174314

Citations 17

Authors

Yann Goueffic

Susan Potter-Perigo

Christina K Chan

Pamela Y Johnson

Kathleen Braun

Steven P Evanko

Thomas N Wight

Affiliations

Soon will be listed here.

Abstract

Sirolimus (SRL), an inhibitor of human arterial smooth muscle cell (ASMC) proliferation and migration, prevents in-stent restenosis (ISR). Little is known about the effect of SRL on the extracellular matrix (ECM) component, hyaluronan, a key macromolecule in neointimal hyperplasia and inflammation. In this study, we investigated SRL regulation of the synthesis of hyaluronan by cultured human ASMC and the effect of SRL on hyaluronan mediated monocyte adhesion to the ECM. Hyaluronan production on a per cell basis was significantly inhibited by SRL at 4 days and remained so through 10 days. This reduction was correlated with reduced levels of hyaluronan synthase mRNAs while hyaluronan degradation rates were unchanged. Poly I:C, a viral mimetic, caused increased hyaluronan accumulation by ASMC cell layers and this increase was inhibited by SRL. The inhibition was paralleled by a reduction in hyaluronan-dependent monocyte adhesion to the ECM. This study demonstrates that SRL not only regulates the proliferation of ASMC but reduces the production of hyaluronan by these cells. This alteration in ECM composition results in reduced monocyte adhesion to the ECM in cultures of ASMC. Alterations in hyaluronan accumulation may contribute to the inhibition of ISR that is achieved by SRL.

Citing Articles

Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.

Bellini A, Finocchietti M, Rosa A, Nordio M, Ferroni E, Massari M PLoS One. 2024; 19(1):e0295205.

PMID: 38165971 PMC: 10760756. DOI: 10.1371/journal.pone.0295205.

Comprehensive view of macrophage autophagy and its application in cardiovascular diseases.

Pan W, Zhang J, Zhang L, Zhang Y, Song Y, Han L Cell Prolif. 2023; 57(1):e13525.

PMID: 37434325 PMC: 10771119. DOI: 10.1111/cpr.13525.

Development of calciphylaxis in kidney transplant recipients with a functioning graft.

Guillen-Olmos E, Torregrosa J, Garcia-Herrera A, Ganau S, Diekmann F, Cucchiari D Clin Kidney J. 2022; 15(4):663-671.

PMID: 35371461 PMC: 8967679. DOI: 10.1093/ckj/sfab205.

Roles of mTOR in thoracic aortopathy understood by complex intracellular signaling interactions.

Estrada A, Irons L, Rego B, Li G, Tellides G, Humphrey J PLoS Comput Biol. 2021; 17(12):e1009683.

PMID: 34898595 PMC: 8700007. DOI: 10.1371/journal.pcbi.1009683.

Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty .

Betala J, Bae S, Langan 3rd E, LaBerge M, Lee J Nanomedicine (Lond). 2020; 15(12):1205-1220.

PMID: 32340540 PMC: 7466912. DOI: 10.2217/nnm-2020-0028.

References

Bauters C, Van Belle E, McFadden E, Lablanche J, Bertrand M . [Restenosis after angioplasty]. Arch Mal Coeur Vaiss. 1999; 92(11 Suppl):1579-82. View

Riessen R, Wight T, Pastore C, HENLEY C, Isner J . Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation. 1996; 93(6):1141-7. DOI: 10.1161/01.cir.93.6.1141. View

Gingras A, Raught B, Sonenberg N . Regulation of translation initiation by FRAP/mTOR. Genes Dev. 2001; 15(7):807-26. DOI: 10.1101/gad.887201. View

Svegliati-Baroni G, Ridolfi F, Di Sario A, Saccomanno S, Bendia E, Benedetti A . Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells. Hepatology. 2001; 33(5):1130-40. DOI: 10.1053/jhep.2001.23788. View

Roque M, Reis E, Cordon-Cardo C, Taubman M, Fallon J, Fuster V . Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest. 2001; 81(6):895-903. DOI: 10.1038/labinvest.3780298. View

Sun J, Marx S, Chen H, Poon M, Marks A, Rabbani L . Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. Circulation. 2001; 103(24):2967-72. DOI: 10.1161/01.cir.103.24.2967. View

Suzuki T, Kopia G, Hayashi S, BAILEY L, Llanos G, Wilensky R . Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 2001; 104(10):1188-93. DOI: 10.1161/hc3601.093987. View

Evanko S, Johnson P, Braun K, Underhill C, Dudhia J, Wight T . Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys. 2001; 394(1):29-38. DOI: 10.1006/abbi.2001.2507. View

Sousa J, Costa M, Abizaid A, Rensing B, Abizaid A, Tanajura L . Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 2001; 104(17):2007-11. DOI: 10.1161/hc4201.098056. View

10.

Ismail A, Khosravi H, Olson H . The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis. 2001; 1(4):233-40. View

11.

Morice M, Serruys P, Sousa J, Fajadet J, Ban Hayashi E, Perin M . A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346(23):1773-80. DOI: 10.1056/NEJMoa012843. View

12.

Klugherz B, Llanos G, Lieuallen W, Kopia G, Papandreou G, Narayan P . Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent. Coron Artery Dis. 2002; 13(3):183-8. DOI: 10.1097/00019501-200205000-00008. View

13.

Karnik S, Brooke B, Bayes-Genis A, Sorensen L, Wythe J, Schwartz R . A critical role for elastin signaling in vascular morphogenesis and disease. Development. 2002; 130(2):411-23. DOI: 10.1242/dev.00223. View

14.

Chung I, Gold H, Schwartz S, Ikari Y, Reidy M, Wight T . Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol. 2002; 40(12):2072-81. DOI: 10.1016/s0735-1097(02)02598-6. View

15.

Sehgal S . Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc. 2003; 35(3 Suppl):7S-14S. DOI: 10.1016/s0041-1345(03)00211-2. View

16.

Marks A . Rapamycin: signaling in vascular smooth muscle. Transplant Proc. 2003; 35(3 Suppl):231S-233S. DOI: 10.1016/s0041-1345(03)00243-4. View

17.

Monslow J, Williams J, Norton N, Guy C, Price I, Coleman S . The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. Int J Biochem Cell Biol. 2003; 35(8):1272-83. DOI: 10.1016/s1357-2725(03)00048-7. View

18.

de la Motte C, Hascall V, Drazba J, Bandyopadhyay S, Strong S . Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol. 2003; 163(1):121-33. PMC: 1868154. DOI: 10.1016/s0002-9440(10)63636-x. View

19.

Majors A, Austin R, de la Motte C, Pyeritz R, Hascall V, Kessler S . Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem. 2003; 278(47):47223-31. DOI: 10.1074/jbc.M304871200. View

20.

Martin K, Rzucidlo E, Merenick B, Fingar D, Brown D, Wagner R . The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol. 2003; 286(3):C507-17. DOI: 10.1152/ajpcell.00201.2003. View